Add to ORKG15 demented patients aged 56-71 years, who underwent a therapeutic trial with DL or L acetyl carnitine for a period ranging from 1 to 12 months were studied. A number of clinical and electrophysiological parameters (P 300) were evaluated before and after the trial to assess the effect of the drug. In about half of our patients an improvement in intellectual performance and behavior was observed, corresponding to a decrease of P 300 latencies. The mechanisms of action of acetyl carnitine in dementia are discussed
Meccanismi neuroendocrini (iperattività dell'asse HPA) sottesi allo sviluppo della demenza degenerat...
Objectives: The aim of this study was to assess, in a natural setting, the development of cognitive,...
Drugs belonging to different chemical classes having the ability to improve behavioral performance i...
15 demented patients aged 56-71 years, who underwent a therapeutic trial with DL or L acetyl carniti...
Valutazione delle performance cognitive in una popolazione di pazienti con malattia di Alzheimer in ...
Several studies explored the effects of acetyl-L-carnitine (ALC) in dementia, suggesting a role in s...
Studio in doppio cieco sugli effetti neuroendocrini e cognitivi di un trattamento con L-acetilcarnit...
Acetyl-L-carnitine (ALCAR) is a drug currently under investigation for Alzheimer disease (AD) therap...
The prevalence of glucocorticoid hypersecretion and the loss of hippocampal inhibition of hypothalam...
A long history of diabetes mellitus and increasing age are associated with the onset of diabetic neu...
Introduction: L-acetylcarnitine (LAC), the acetyl ester of carnitine naturally present in the centra...
The aim of the present study was to investigate the neuronal structure sthat mediate the Antiaging ...
The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-p...
This paper has reviewed the documentation on the clinical efficacy of choline alphoscerate, a cholin...
Acetyl-L-carnitine produces a significant increase in the survival time-course of adult rat sensory ...
Meccanismi neuroendocrini (iperattività dell'asse HPA) sottesi allo sviluppo della demenza degenerat...
Objectives: The aim of this study was to assess, in a natural setting, the development of cognitive,...
Drugs belonging to different chemical classes having the ability to improve behavioral performance i...
15 demented patients aged 56-71 years, who underwent a therapeutic trial with DL or L acetyl carniti...
Valutazione delle performance cognitive in una popolazione di pazienti con malattia di Alzheimer in ...
Several studies explored the effects of acetyl-L-carnitine (ALC) in dementia, suggesting a role in s...
Studio in doppio cieco sugli effetti neuroendocrini e cognitivi di un trattamento con L-acetilcarnit...
Acetyl-L-carnitine (ALCAR) is a drug currently under investigation for Alzheimer disease (AD) therap...
The prevalence of glucocorticoid hypersecretion and the loss of hippocampal inhibition of hypothalam...
A long history of diabetes mellitus and increasing age are associated with the onset of diabetic neu...
Introduction: L-acetylcarnitine (LAC), the acetyl ester of carnitine naturally present in the centra...
The aim of the present study was to investigate the neuronal structure sthat mediate the Antiaging ...
The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-p...
This paper has reviewed the documentation on the clinical efficacy of choline alphoscerate, a cholin...
Acetyl-L-carnitine produces a significant increase in the survival time-course of adult rat sensory ...
Meccanismi neuroendocrini (iperattività dell'asse HPA) sottesi allo sviluppo della demenza degenerat...
Objectives: The aim of this study was to assess, in a natural setting, the development of cognitive,...
Drugs belonging to different chemical classes having the ability to improve behavioral performance i...